Dianthus Therapeutics Inc (DNTH)

09:49 AM

Strength seen in Dianthus Therapeutics, Inc. (DNTH): Can its 5.6% jump turn into more strength? - MSN

09:49 AM

02:31 AM

Dianthus Therapeutics shares jump 25% after encouraging clinical trial update - MSN

02:31 AM

Apr 14, 2026

Dianthus Therapeutics CFO Sells $9.5 Million in Stock - AOL.com

Apr 14, 2026

Apr 14, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Sets New 1-Year HighShould You Buy? - MarketBeat

Apr 14, 2026

Apr 11, 2026

Dianthus Therapeutics EVP Sells $10M in Shares - National Today

Apr 11, 2026

Apr 11, 2026

SG Americas Securities LLC Invests $765,000 in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Apr 11, 2026

Apr 11, 2026

DNTH SEC FilingsDianthus Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 11, 2026

Apr 10, 2026

Dianthus Therapeutics (NASDAQ:DNTH) EVP Ryan Savitz Sells 8,224 Shares - MarketBeat

Apr 10, 2026

Apr 10, 2026

Ryan Savitz, Dianthus Therapeutics CFO, sells $738k in DNTH stock - Investing.com Canada

Apr 10, 2026

Apr 10, 2026

Dianthus Therapeutics Insider Sold Shares Worth $738,844, According to a Recent SEC Filing - marketscreener.com

Apr 10, 2026

Apr 10, 2026

Dianthus (NASDAQ: DNTH) CFO exercises options, sells 8,224 shares under 10b5-1 plan - Stock Titan

Apr 10, 2026

Apr 10, 2026

Dianthus Therapeutics Upgraded to Strong Buy at Wolfe Research - National Today

Apr 10, 2026

Apr 10, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Upgraded by Wolfe Research to "Strong-Buy" Rating - MarketBeat

Apr 10, 2026

Apr 09, 2026

Dianthus Therapeutics stock hits 52-week high at 90.2 USD By Investing.com - Investing.com Australia

Apr 09, 2026

Apr 09, 2026

Ryan Savitz files Form 144 to sell 8,224 shares (NASDAQ: DNTH) - Stock Titan

Apr 09, 2026

Apr 09, 2026

Dianthus Therapeutics (DNTH) details 2026 director, pay and auditor votes - Stock Titan

Apr 09, 2026

Apr 09, 2026

Dianthus Therapeutics stock hits 52-week high at 90.2 USD - Investing.com

Apr 09, 2026

Apr 09, 2026

Wolfe Research Begins Coverage on Dianthus Therapeutics (NASDAQ:DNTH) - MarketBeat

Apr 09, 2026

Apr 08, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Sets New 12-Month HighTime to Buy? - MarketBeat

Apr 08, 2026

Apr 08, 2026

Can Dianthus Therapeutics Inc expand into new marketsEarnings Growth Report & Low Risk High Reward Ideas - baoquankhu1.vn

Apr 08, 2026

Apr 08, 2026

Dianthus Therapeutics, Inc.Common Stock (DNTH) Stock Price, News, Quote & History - FinancialContent

Apr 08, 2026

Apr 07, 2026

Dianthus Therapeutics Announces Inducement Grants - National Today

Apr 07, 2026

Apr 06, 2026

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 06, 2026

Apr 06, 2026

Dianthus Therapeutics CFO Sells $9.5 Million in Stock - The Motley Fool

Apr 06, 2026

Apr 06, 2026

JPMorgan Chase & Co. Has $2.68 Million Stock Position in Dianthus Therapeutics, Inc. $DNTH - MarketBeat

Apr 06, 2026

Apr 06, 2026

Dianthus gives 8 new employees stock options at $84.56 a share - Stock Titan

Apr 06, 2026

Apr 05, 2026

Aug Momentum: Can Dianthus Therapeutics Inc expand into new markets2026 Retail Activity & AI Enhanced Trading Alerts - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026

Dianthus Therapeutics, Inc. (DNTH) stock price, news, quote and history - Yahoo Finance UK

Apr 04, 2026

Apr 04, 2026

A Look At Dianthus Therapeutics (DNTH) Valuation After A Strong Year Of Share Price Gains - Sahm

Apr 04, 2026

Apr 03, 2026

Wedbush keeps outperform on Dianthus Therapeutics, Inc. (DNTH), highlights potential of Claseprubart in CIDP - MSN

Apr 03, 2026

Apr 03, 2026

Dianthus Therapeutics EVP Sells Over $9 Million in Shares - National Today

Apr 03, 2026

Apr 03, 2026

How Investors May Respond To Dianthus Therapeutics (DNTH) Early “GO” Decision And FDA Backing For Claseprubart - Yahoo Finance

Apr 03, 2026

Apr 02, 2026

Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $9,492,461.00 in Stock - MarketBeat

Apr 02, 2026

Apr 02, 2026

Dianthus Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144 - Moomoo

Apr 02, 2026

Apr 02, 2026

Wells Fargo Remains a Buy on Dianthus Therapeutics (DNTH) - The Globe and Mail

Apr 02, 2026

Apr 01, 2026

Dianthus Therapeutics(DNTH.US) Officer Sells US$9.49 Million in Common Stock - Moomoo

Apr 01, 2026

Apr 01, 2026

Dianthus Therapeutics stock hits 52-week high at 88.35 USD By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Dianthus therapeutics director Soteropoulos sells $47985 in stock By Investing.com - Investing.com Australia

Apr 01, 2026

Apr 01, 2026

Dianthus therapeutics director Soteropoulos sells $47985 in stock - Investing.com

Apr 01, 2026

Apr 01, 2026

Savitz of Dianthus sold $9.5m in DNTH stock - Investing.com UK

Apr 01, 2026

Apr 01, 2026

Savitz of Dianthus sold $9.5m in DNTH stock By Investing.com - Investing.com South Africa

Apr 01, 2026

Apr 01, 2026

Dianthus Therapeutics Insider Sold Shares Worth $9,492,596, According to a Recent SEC Filing - marketscreener.com

Apr 01, 2026

Apr 01, 2026

Dianthus Therapeutics (DNTH) CFO exercises options, sells 114,367 shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Dianthus Therapeutics (DNTH) director exercises options then sells 599 shares - Stock Titan

Apr 01, 2026

Apr 01, 2026

Dianthus Therapeutics (NASDAQ:DNTH) Sets New 52-Week HighTime to Buy? - MarketBeat

Apr 01, 2026

Apr 01, 2026

Dianthus Therapeutics stock hits 52-week high at 88.35 USD - Investing.com

Apr 01, 2026

Apr 01, 2026

Dianthus rises as FDA agrees with proposed changes to lead program - MSN

Apr 01, 2026